Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2002 1
2005 2
2006 1
2008 1
2010 1
2011 2
2012 5
2013 3
2014 1
2015 2
2016 4
2017 1
2018 1
2019 5
2020 1
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Pasireotide in the Personalized Treatment of Acromegaly.
Puig-Domingo M, Bernabéu I, Picó A, Biagetti B, Gil J, Alvarez-Escolá C, Jordà M, Marques-Pamies M, Soldevila B, Gálvez MA, Cámara R, Aller J, Lamas C, Marazuela M. Puig-Domingo M, et al. Among authors: galvez ma. Front Endocrinol (Lausanne). 2021 Mar 16;12:648411. doi: 10.3389/fendo.2021.648411. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33796079 Free PMC article. Review.
Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly.
Ruiz S, Gil J, Biagetti B, Venegas E, Cámara R, Garcia-Centeno R, Gálvez MÁ, Picó A, Maraver S, González I, Abellán P, Trincado P, Herrera M, Olvera P, Xifra G, Bernabeu I, Serra-Soler G, Azriel S, García L, Carvalho D, Jordà M, Valassi E, Puig J, Puig-Domingo M. Ruiz S, et al. Among authors: galvez ma. Clin Endocrinol (Oxf). 2023 Oct;99(4):378-385. doi: 10.1111/cen.14946. Epub 2023 Jul 8. Clin Endocrinol (Oxf). 2023. PMID: 37421211
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma.
Mellid S, Gil E, Letón R, Caleiras E, Honrado E, Richter S, Palacios N, Lahera M, Galofré JC, López-Fernández A, Calatayud M, Herrera-Martínez AD, Galvez MA, Matias-Guiu X, Balbín M, Korpershoek E, Lim ES, Maletta F, Lider S, Fliedner SMJ, Bechmann N, Eisenhofer G, Canu L, Rapizzi E, Bancos I, Robledo M, Cascón A. Mellid S, et al. Among authors: galvez ma. Front Endocrinol (Lausanne). 2023 Jan 25;13:1070074. doi: 10.3389/fendo.2022.1070074. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36760809 Free PMC article.
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Remacha L, Pirman D, Mahoney CE, Coloma J, Calsina B, Currás-Freixes M, Letón R, Torres-Pérez R, Richter S, Pita G, Herráez B, Cianchetta G, Honrado E, Maestre L, Urioste M, Aller J, García-Uriarte Ó, Gálvez MÁ, Luque RM, Lahera M, Moreno-Rengel C, Eisenhofer G, Montero-Conde C, Rodríguez-Antona C, Llorca Ó, Smolen GA, Robledo M, Cascón A. Remacha L, et al. Among authors: galvez ma. Am J Hum Genet. 2019 Apr 4;104(4):651-664. doi: 10.1016/j.ajhg.2019.02.017. Epub 2019 Mar 28. Am J Hum Genet. 2019. PMID: 30929736 Free PMC article.
Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas.
Alhambra-Expósito MR, Ibáñez-Costa A, Moreno-Moreno P, Rivero-Cortés E, Vázquez-Borrego MC, Blanco-Acevedo C, Toledano-Delgado Á, Lombardo-Galera MS, Vallejo-Casas JA, Gahete MD, Castaño JP, Gálvez MA, Luque RM. Alhambra-Expósito MR, et al. Among authors: galvez ma. Sci Rep. 2018 Apr 18;8(1):6173. doi: 10.1038/s41598-018-24260-y. Sci Rep. 2018. PMID: 29670116 Free PMC article.
[Clinical trials (III). The publication of the results].
Pascual J, de Pablo I, Gálvez MA, Hernández D. Pascual J, et al. Among authors: galvez ma. Nefrologia. 2006;26(1):25-30. Nefrologia. 2006. PMID: 16649423 Free article. Review. Spanish. No abstract available.
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Remacha L, Pirman D, Mahoney CE, Coloma J, Calsina B, Currás-Freixes M, Letón R, Torres-Pérez R, Richter S, Pita G, Herráez B, Cianchetta G, Honrado E, Maestre L, Urioste M, Aller J, García-Uriarte Ó, Gálvez MÁ, Luque RM, Lahera M, Moreno-Rengel C, Eisenhofer G, Montero-Conde C, Rodríguez-Antona C, Llorca Ó, Smolen GA, Robledo M, Cascón A. Remacha L, et al. Among authors: galvez ma. Am J Hum Genet. 2019 May 2;104(5):1008-1010. doi: 10.1016/j.ajhg.2019.04.010. Am J Hum Genet. 2019. PMID: 31051110 Free PMC article. No abstract available.
A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors.
Vázquez-Borrego MC, Gupta V, Ibáñez-Costa A, Gahete MD, Venegas-Moreno E, Toledano-Delgado Á, Cano DA, Blanco-Acevedo C, Ortega-Salas R, Japón MA, Barrera-Martín A, Vasiljevic A, Hill J, Zhang S, Halem H, Solivera J, Raverot G, Gálvez MA, Soto-Moreno A, Paez-Pereda M, Culler MD, Castaño JP, Luque RM. Vázquez-Borrego MC, et al. Among authors: galvez ma. Clin Cancer Res. 2020 Feb 15;26(4):957-969. doi: 10.1158/1078-0432.CCR-19-2154. Epub 2019 Oct 17. Clin Cancer Res. 2020. PMID: 31624102
Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.
Ibáñez-Costa A, Rivero-Cortés E, Vázquez-Borrego MC, Gahete MD, Jiménez-Reina L, Venegas-Moreno E, de la Riva A, Arráez MÁ, González-Molero I, Schmid HA, Maraver-Selfa S, Gavilán-Villarejo I, García-Arnés JA, Japón MA, Soto-Moreno A, Gálvez MA, Luque RM, Castaño JP. Ibáñez-Costa A, et al. Among authors: galvez ma. J Endocrinol. 2016 Nov;231(2):135-145. doi: 10.1530/JOE-16-0332. Epub 2016 Sep 1. J Endocrinol. 2016. PMID: 27587848 Free article.
36 results